Recently, a series of SAMHD1 mutations have been reported in various cancer cells including leukemias (38, 39, 40, 41, 42), lymphomas (43, 44), lung cancer (45), and colon cancer (46, 47, 48). This evidence concerns the gene SAMHD1 and leukemia.